Clinical Trials in Georgia (GA) | Georgia Clinical Drug Trials & Studies

You are viewing Clinical Trials In Georgia

Have multiple conditions? Click here

Showing 1-100 of 1746

There are 1746 trials in Georgia

Name	City	State	Zip
Study of Asimadoline to Treat Diarrhea-Predominant Irritable Bowel Syndrome (D-IBS)	Woodstock	GA	30189
TC-6987 for the Treatment of Mild to Moderate Asthma	Woodstock	GA	30188
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus	Waycross	GA	31501
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer	Valdosta	GA	31603
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Valdosta	GA	31603
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Valdosta	GA	31603
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	Valdosta	GA	31603
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus	Tucker	GA	30084
Ranolazine, Ethnicity and the Metabolic Syndrome	Tucker	GA	30084
Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI	Tucker	GA	30084
Immunogenicity of Off-Schedule Dosing of HPV Vaccine	Tucker	GA	30084
Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)	Tucker	GA	30084
BI 10773 Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients.	Tucker	GA
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by 54 Week Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes	Tucker	GA
Clinical Study to Investigate the Effectiveness of the TOPAS Sling System to Treat Fecal Incontinence	Toccoa	GA	30577
Trenev Trio/Healthy Trinity for Symptoms of Diarrhea-predominant Irritable Bowel Syndrome (IBS) and Functional Dyspepsia	Suwanee-Duluth	GA	30096
Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone	Suwanee	GA	30024
Welchol as Monotherapy for Type 2 Diabetes Mellitus	Stone Mountain	GA	30083
Welchol as Monotherapy for Type 2 Diabetes Mellitus	Stockbridge	GA	30281
Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus	Stockbridge	GA	30281
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Patients With Systemic Lupus Erythematosus	Stockbridge	GA	30281
Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension	Stockbridge	GA	30281
An Observational Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants	Snellville	GA	30078
Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea	Snellville	GA	30078
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne	Snellville	GA	30078
Dose-Finding Study of Favipiravir in the Treatment of Uncomplicated Influenza	Snellville	GA
Comparison of Tiotropium in the HandhiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease	Snellville	GA
A Trial of CM-AT in Children With Autism	Smyrna	GA	30080
Study of Arbaclofen for the Treatment of Social Withdrawal in Subjects With Autism Spectrum Disorders	Smyrna	GA	30080
Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depresstion	Smyrna	GA	30080
Switching to Iloperidone From Other Antipsychotics in Schizophrenia	Smyrna	GA	30080
OPT - Phase IV Long Term Maintenance Study of Aripiprazole for the Treatment of Irritability Associated With Autistic Disorder	Smyrna	GA	30080
Safety and Efficacy of F2695 SR in Major Depressive Disorder	Smyrna	GA	30080
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder	Smyrna	GA	30080
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder	Smyrna	GA	30080
Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder	Smyrna	GA	30080
Switching to Iloperidone From Other Antipsychotics in Schizophrenia	Smyrna	GA	30080
Safety and Efficacy of EVT 101 in Treatment-Resistant Depression	Smyrna	GA
Safety Study of ExAblate for the Treatment of Uterine Fibroids	Smyrna	GA	30080
Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (Study P05896)	Smyrna	GA	30080
Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (Study P05897)	Smyrna	GA	30080
Paclitaxel in Treating Patients With Ovarian Stromal Cancer	Savannah	GA	31403
Isotretinoin With or Without Monoclonal Antibody, Interleukin-2, and Sargramostim Following Stem Cell Transplantation in Treating Patients With Neuroblastoma	Savannah	GA	31403
Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors	Savannah	GA	31403
Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Savannah	GA	31403
Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma	Savannah	GA	31403
Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer	Savannah	GA	31403
Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer	Savannah	GA	31403
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer	Savannah	GA	31403
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery	Savannah	GA	31403
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors	Savannah	GA	31403
Vincristine, Dactinomycin, and Doxorubicin With or Without Radiation Therapy or Observation Only in Treating Younger Patients Who Are Undergoing Surgery for Newly Diagnosed Stage I, Stage II, or Stage III Wilms' Tumor	Savannah	GA	31403
Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma	Savannah	GA	31403
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia	Savannah	GA	31403
Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor	Savannah	GA	31403
Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia	Savannah	GA	31403
Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor	Savannah	GA	31403
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma	Savannah	GA	31403
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer	Savannah	GA	31403
Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma	Savannah	GA	31403
Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery	Savannah	GA	31403
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy	Savannah	GA	31403
Neuropsychological and Behavioral Testing in Young Patients With Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor (PNET)	Savannah	GA	31403
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer	Savannah	GA	31403
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer	Savannah	GA	31403
Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer	Savannah	GA	31403
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery	Savannah	GA	31403
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Promyelocytic Leukemia	Savannah	GA	31403
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement	Savannah	GA	31403
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases	Savannah	GA	31403
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma	Savannah	GA	31403
Collecting Tumor Samples From Patients With Gynecological Tumors	Savannah	GA	31403
Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer	Savannah	GA	31403
Study of Kidney Tumors in Young Patients	Savannah	GA	31403
Collecting and Storing Samples of Blood and Tumor Tissue From Patients With Osteosarcoma	Savannah	GA	31403
Collecting and Storing Biological Samples From Patients With Ewing Sarcoma	Savannah	GA	31403
Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma	Savannah	GA	31403
Collecting and Storing Tissue, Blood, and Bone Marrow Samples From Patients With Rhabdomyosarcoma or Other Soft Tissue Sarcoma	Savannah	GA	31403
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer	Savannah	GA	31403
Combination Chemotherapy and Surgery in Treating Young Patients With Wilms Tumor	Savannah	GA	31403
Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	Savannah	GA	31403
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer	Savannah	GA	31403
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	Savannah	GA	31403
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Liver Cancer	Savannah	GA	31403
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma	Savannah	GA	31403
Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma	Savannah	GA	31403
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer	Savannah	GA	31403
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma	Savannah	GA	31403
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy	Savannah	GA	31403
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Savannah	GA	31403
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery	Savannah	GA	31403
Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	Savannah	GA	31403
Risk-Adapted Chemotherapy in Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia	Savannah	GA	31403
Vinorelbine Ditartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma	Savannah	GA	31403
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma	Savannah	GA	31403
Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM)	Savannah	GA	31404
An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer	Savannah	GA	31404
Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse	Savannah	GA	31404
A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer	Savannah	GA	31404
Efficacy and Safety Study of DP-b99 in Treating Acute Ischemic Stroke	Savannah	GA	31404

View Clinical Trial Facilities in Georgia

Showing 1-100 of 1746